Ireland: HSE expands hepatitis C treatment

Will extend the clinical eligibility to Directly Acting Antivirals drug treatments to “eliminate Hepatitis C in Ireland by 2026″.  An estimated 20,000-50,000 people there are chronically infected, alongside new HIV cases in injecting drug users more than doubling.